scholarly journals Studying the content characteristics of New Technology-Based Firms

2020 ◽  
Vol 3 (1) ◽  
pp. 94-111
Author(s):  
Hasan Boudlaie ◽  
Mohammadhosein Kenarroodi ◽  
Behrouz Keshavarz Nik

New technology-based firms (NTBFs) have a significant contribution to economic growth, and in particular to the promotion of innovation and job creation. For this reason, many countries are seeking to establish and grow such institutions using incentive policies. Despite their economic importance, there is no single definition of these companies and several definitions for these types of companies are tailored to the purpose of each study. As for the nature of study, it is important to produce a coherent framework of NTBFs’ characteristics; therefore, the purpose of the present study is to identify the characteristics of NTBFs. For this purpose, the researches that covered the nature of this concept from 1990 to 2011 were analyzed using content analysis. In the first phase, definitions of these companies were compiled; subsequently, effective characteristics were identified to provide a clear nature of these companies. The results of this research led to the identification, confirmation and prioritization of five characteristics, i.e. newness, possessing high-technology, independence, small size in terms of employees and volume of sales, and capital funding by company founders, all of which were prioritized according to the most frequent characteristics in the studied articles. The final result of this study is to guide and streamline future research by achieving theoretical coherence in defining this concept.

2018 ◽  
pp. 1654-1670
Author(s):  
Johanne Queenton ◽  
Sophie Veilleux

As organizations based on science, dedicated biotechnology firms (DBFs) establish very narrow links with universities and public research institutions in developing their technologies. This chapter examines the influence of DBF relationships with star bioscientists on their venture-capital funding. It proposes a new definition of bioscientists anchored in today's technological practices. It also classifies Canadian bioscientists into four categories to give a national overview of their involvement with DBFs. The cross-analysis of 150 Canadian DBFs active in human-health applications and 431 bioscientists confirms the positive impact of these relationships on obtaining venture capital when a star is involved because of the credibility it brings to the firm. Moreover, results show that bioscientists most often chose to establish contractual agreements with existing firms or start their own. Future research directions and implications for policy makers are discussed.


2018 ◽  
Vol 12 (1) ◽  
pp. 14-31 ◽  
Author(s):  
Tetsuya Kirihata

Purpose The purpose of this paper is to discuss the implication of Japanese government venture capital (VC) policies for future research and to provide basis for policymakers and practitioners. Design/methodology/approach This is an academic literature review of available peer-reviewed publications on government VC policies. This paper discusses and analyses the current state and issues of the Japanese government VC policies regarding three research questions: What do Japanese government VCs do? Do they contribute to their portfolios? and Do they contribute to the development of VC market? Findings There are mainly two findings in this paper: It is effective to establish a complementary relationship with private VCs for Japanese government VCs to contribute to their portfolios; Japanese government should simultaneously continue to make and review policies for the VC market, the stock market, the entrepreneur sector and the environment surrounding them by its strategic long-term commitment to contribute to the development of VC market and new technology-based firms in Japan. Originality/value As there are only a few studies on recently strengthened Japanese government VC policies, this paper provides an in-depth discussion on these Japanese VC policies, which can be used for future research and as a valuable resource for policymakers and practitioners.


2006 ◽  
Vol 10 (04) ◽  
pp. 351-374 ◽  
Author(s):  
MARINA CANDI

Design is increasingly gaining recognition as a fruitful means to improve business performance. Technology-based firms are an important source of innovation, and therefore it is important to develop a means to study the relationship between technology-based firms' emphasis on design as an element of innovation and their performance. This article develops a model for evaluating technology-based firms' design emphasis. The model is based on a synthesis approach to studying innovation in both services and manufacturing and a three-dimensional definition of design. The application of the model is demonstrated using a set of new technology-based firms. The empirical study confirms the appropriateness of using the synthesis approach for studying design as an element of innovation in technology-based firms. The application of the model provides a classification which can be used as a basis for studying the relationship between design emphasis and performance.


2017 ◽  
Vol 14 (04) ◽  
pp. 1750023 ◽  
Author(s):  
Vincent Blok ◽  
Sander Thijssen ◽  
Stefano Pascucci

Following the call for process-oriented research on business incubation processes, this paper investigates the process of business incubation (BI) via an understanding of management practices and interactions. Based on a comprehensive literature review and empirical evidence of management practices in business incubators ([Formula: see text]) dealing with new technology-based firms (NTBFs), we develop a conceptual model of factors having an impact on the incubation process of NTBFs, including propositions that can be tested in future research. Our results show that a combination of six management practices enables BI managers to accelerate the learning curve of entrepreneurs and the start-up process of their firms. Our results help to theorize about the factors having an impact on the incubation process of NTBFs and the dynamics behind the incubation process, and will enable BI managers to develop practices that really help entrepreneurs in the development of their NTBF.


Author(s):  
Johanne Queenton ◽  
Sophie Veilleux

As organizations based on science, dedicated biotechnology firms (DBFs) establish very narrow links with universities and public research institutions in developing their technologies. This chapter examines the influence of DBF relationships with star bioscientists on their venture-capital funding. It proposes a new definition of bioscientists anchored in today's technological practices. It also classifies Canadian bioscientists into four categories to give a national overview of their involvement with DBFs. The cross-analysis of 150 Canadian DBFs active in human-health applications and 431 bioscientists confirms the positive impact of these relationships on obtaining venture capital when a star is involved because of the credibility it brings to the firm. Moreover, results show that bioscientists most often chose to establish contractual agreements with existing firms or start their own. Future research directions and implications for policy makers are discussed.


Author(s):  
Eduardo Bueno Campos ◽  
Mónica Longo Somoza ◽  
M. Paz Salmador

This chapter studies the relations between the emergent concept of Organizational Identity and the concept of Intellectual Capital. Specifically, the chapter focuses on the idea that when new technology-based firms develop the social process of construction of their Organizational Identity, at the same time they develop the social interaction needed to define variables of their Organizational Capital. This proposition is grounded in a theoretical review of the concept of Organizational Identity and Organizational Capital in the Intellectus Model, and it is empirically tested in five case studies of new technology-based firms created at Madrid Science Park. Finally, the limitations and suggestions for future research as well as conclusions of the study are presented.


2021 ◽  
Vol 42 (1) ◽  
pp. e8-e16 ◽  
Author(s):  
Angelica Tiotiu

Background: Severe asthma is a heterogeneous disease that consists of various phenotypes driven by different pathways. Associated with significant morbidity, an important negative impact on the quality of life of patients, and increased health care costs, severe asthma represents a challenge for the clinician. With the introduction of various antibodies that target type 2 inflammation (T2) pathways, severe asthma therapy is gradually moving to a personalized medicine approach. Objective: The purpose of this review was to emphasize the important role of personalized medicine in adult severe asthma management. Methods: An extensive research was conducted in medical literature data bases by applying terms such as “severe asthma” associated with “structured approach,” “comorbidities,” “biomarkers,” “phenotypes/endotypes,” and “biologic therapies.” Results: The management of severe asthma starts with a structured approach to confirm the diagnosis, assess the adherence to medications and identify confounding factors and comorbidities. The definition of phenotypes or endotypes (phenotypes defined by mechanisms and identified through biomarkers) is an important step toward the use of personalized medicine in asthma. Severe allergic and nonallergic eosinophilic asthma are two defined T2 phenotypes for which there are efficacious targeted biologic therapies currently available. Non-T2 phenotype remains to be characterized, and less efficient target therapy exists. Conclusion: Despite important progress in applying personalized medicine to severe asthma, especially in T2 inflammatory phenotypes, future research is needed to find valid biomarkers predictive for the response to available biologic therapies to develop more effective therapies in non-T2 phenotype.


Author(s):  
Fred Luthans ◽  
Carolyn M. Youssef

Over the years, both management practitioners and academics have generally assumed that positive workplaces lead to desired outcomes. Unlike psychology, considerable attention has also been devoted to the study of positive topics such as job satisfaction and organizational commitment. However, to place a scientifically based focus on the role that positivity may play in the development and performance of human resources, and largely stimulated by the positive psychology initiative, positive organizational behavior (POB) and psychological capital (PsyCap) have recently been introduced into the management literature. This chapter first provides an overview of both the historical and contemporary positive approaches to the workplace. Then, more specific attention is given to the meaning and domain of POB and PsyCap. Our definition of POB includes positive psychological capacities or resources that can be validly measured, developed, and have performance impact. The constructs that have been determined so far to best meet these criteria are efficacy, hope, optimism, and resiliency. When combined, they have been demonstrated to form the core construct of what we term psychological capital (PsyCap). A measure of PsyCap is being validated and this chapter references the increasing number of studies indicating that PsyCap can be developed and have performance impact. The chapter concludes with important future research directions that can help better understand and build positive workplaces to meet current and looming challenges.


Sign in / Sign up

Export Citation Format

Share Document